Recurrent Sarcoma Not Yet Recruiting Phase 0 Trials for Polyethylene glycol 400 (DB11077)

Indication	Status	Phase
DBCOND0124737 (Recurrent Sarcoma)	Not Yet Recruiting	0

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04199026	Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma	Other	Cyclophosphamide (DB00531) Daunorubicin (DB00694) Doxorubicin (DB00997) Everolimus (DB01590) Ganitumab (DB12205) Ifosfamide (DB01181) Irinotecan (DB00762) Menthol (DB14123) Pazopanib (DB06589) Polyethylene glycol (DB09287) Polyethylene glycol 400 (DB11077) Sirolimus (DB00877) Temozolomide (DB00853) Temsirolimus (DB06287) Vincristine (DB00541)